DRUG REPURPOSING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)
Segmentation
By ApproachDisease centric · Target centric · and Drug centric
By Drug TypeSmall molecules and Biologics
By Therapeutic AreaOncology · Neurology and CNS disorders · Infectious diseases · Cardiovascular diseases · Metabolic disorders · and Other therapeutic areas
By Route of AdministrationOral · Intravenous (IV) · and Other routes
By End UserPharmaceutical and biotechnology companies · Contract research organizations (CROs) · Hospitals and Clinics · and Others
By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
Published In30 Mar 2026
Report CodeCMI8940
Pages250+
FormatsExcel and PDF
Base Year2025
Estimated Year2026
Historical Range2020 - 2024
Forecast Period2026-2033
Market Segmentation
Approach Insights (Revenue, USD Bn, 2021 - 2033)
Disease‑centric
Target‑centric
Drug‑centric
Drug Type Insights (Revenue, USD Bn, 2021 - 2033)
Small molecules
Biologics
Therapeutic Area Insights (Revenue, USD Bn, 2021 - 2033)
Oncology
Neurology and CNS disorders
Infectious diseases
Cardiovascular diseases
Metabolic disorders
Other therapeutic areas
Route Of Administration Insights (Revenue, USD Bn, 2021 - 2033)